The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Share News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 49.85
Bid: 50.10
Ask: 50.30
Change: -2.35 (-4.50%)
Spread: 0.20 (0.399%)
Open: 53.40
High: 53.40
Low: 49.85
Prev. Close: 52.20
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IP Group net asset value dented by global market rout

Tue, 14th Jun 2022 11:55

(Alliance News) - IP Group PLC on Tuesday said its net asset value has fallen since the start of 2022 as global stock market movements hit its public portfolio.

Net asset value per share fell to 139 pence at May 31 from 167p at the end of December, as its total net asset value shrank to GBP1.44 billion from GBP1.74 billion.

"The fall in value in the year to date is largely attributable to the reduction in value of the group's public portfolio which has been impacted by the correction in global stock markets, particularly by the rotation out of growth and technology stocks," the London-based firm explained.

Its public portfolio recorded a fair value reduction of GBP360 million while its private portfolio rose by GBP60 million, it said.

Despite the recent turbulence, the firm said it believes the prospects for its portfolio are strong.

"The board continues to consider that shareholder returns will be driven primarily by long-term capital appreciation. The board remains committed to delivering a regular dividend income, which is intended to comprise a relatively small component of total shareholder return. We will also continue to consider share buyback programmes and other capital return tools as we generate realisations from our portfolio," IP Group added.

IP Group shares were 0.3% lower at 71.30 pence on Tuesday in London.

By Tom Budszus; tombudszus@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
6 Jan 2021 09:07

IP Group Invests GBP4.0 Million In Oxbotica Series B Funding Round

IP Group Invests GBP4.0 Million In Oxbotica Series B Funding Round

Read more
6 Jan 2021 08:25

IP Group's Oxbiotica raises £36m in series B round

(Sharecast News) - Intellectual property investor IP Group announced on Wednesday that its autonomous vehicle software portfolio company Oxbotica has raised £36m of new capital in a series B round, from both new and existing investors.

Read more
3 Dec 2020 09:58

IP Group's Artios Lands Bumper Oncology Pact With Merck KGaA

IP Group's Artios Lands Bumper Oncology Pact With Merck KGaA

Read more
3 Dec 2020 09:08

IP Group's Artios signs research deal with Merck

(Sharecast News) - IP Group said its Artios portfolio company had signed a research deal with Merck of Germany that could more than double the value of the investment company's stake.

Read more
13 Oct 2020 10:37

UK WINNERS & LOSERS SUMMARY: SSE Rises On Energy-From-Waste Sale

UK WINNERS & LOSERS SUMMARY: SSE Rises On Energy-From-Waste Sale

Read more
13 Oct 2020 09:58

IP Group's Oxford Nanopore Raises New Cash Amid Virus Test Progress

IP Group's Oxford Nanopore Raises New Cash Amid Virus Test Progress

Read more
13 Oct 2020 08:30

IP Group portfolio firm Oxford Nanopore raises another £84.4m

(Sharecast News) - Intellectual property-based business investor IP Group announced on Tuesday that its portfolio company Oxford Nanopore Technologies has raised an additional £84.4m of new capital from existing and new investors, including International Holdings Company (IHC) and RPMI Railpen.

Read more
9 Oct 2020 10:37

IP Group Notes CE Mark For Oxford Nanopore's LamPORE Covid-19 Test

IP Group Notes CE Mark For Oxford Nanopore's LamPORE Covid-19 Test

Read more
7 Oct 2020 10:57

IP Group portfolio business offloads cystic fibrosis treatment programme to Roche

(Sharecast News) - Intellectual property company IP Group said on Wednesday that portfolio group Enterprise Therapeutics' TMEM16A cystic fibrosis treatment programme had been acquired by Swiss pharmaceutical giant Roche.

Read more
7 Oct 2020 08:55

TOP NEWS: IP Group Notes Roche's Enterprise Therapeutics Program Buy

TOP NEWS: IP Group Notes Roche's Enterprise Therapeutics Program Buy

Read more
7 Oct 2020 07:54

LONDON BRIEFING: Tesco Profits Surge Amid Stocking Up By Consumers

LONDON BRIEFING: Tesco Profits Surge Amid Stocking Up By Consumers

Read more
7 Oct 2020 07:40

LONDON MARKET PRE-OPEN: Tesco Lifts Interim Payout 21% As Profit Rises

LONDON MARKET PRE-OPEN: Tesco Lifts Interim Payout 21% As Profit Rises

Read more
10 Aug 2020 09:43

UK BROKER RATINGS SUMMARY: RBC Upgrades Hastings To Sector Perform

UK BROKER RATINGS SUMMARY: RBC Upgrades Hastings To Sector Perform

Read more
6 Aug 2020 09:38

UK BROKER RATINGS SUMMARY: Liberum Says Buy XP Power, Cuts PageGroup

UK BROKER RATINGS SUMMARY: Liberum Says Buy XP Power, Cuts PageGroup

Read more
5 Aug 2020 11:04

IP Group Net Asset Value Declines Amid Record Cash Realisations

IP Group Net Asset Value Declines Amid Record Cash Realisations

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.